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effects of skeletal site and age of donor. We previously reported superior differentiation capacity and 
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Abstract
Bone marrow stromal cells (BMSCs) contain osteoprogenitors responsive to stimulation by
osteogenic growth factors like bone morphogenetic proteins (BMPs). When used as grafts, BMSCs
can be harvested from different skeletal sites such as axial, appendicular and orofacial bones, but the
lower therapeutic efficacy of BMPs on BMSCs-responsiveness in humans compared to animal
models may be partly due to effects of skeletal site and age of donor. We previously reported superior
differentiation capacity and osteogenic properties of orofacial BMSCs relative to iliac crest BMSCs
in same individuals. This study tested the hypothesis that recombinant human BMP-2 (rhBMP-2)
stimulates human BMSCs differently based on age and skeletal site of harvest. Adult maxilla,
mandible and iliac crest BMSCs from same individuals and pediatric iliac crest BMSCs were
comparatively assessed for BMP-2 responsiveness under serum-containing and serum-free insulin-
supplemented culture conditions. Adult orofacial BMSCs were more BMP-2-responsive than iliac
crest BMSCs based on higher gene transcripts of alkaline phosphatase, osteopontin and osteogenic
transcription factors MSX-2 and Osterix in serum-free insulin-containing medium. Pediatric iliac
crest BMSCs were more responsive to rhBMP-2 than adult iliac crest BMSCs based on higher
expression of alkaline phosphatase and osteopontin in serum-containing medium. Unlike orofacial
BMSCs, MSX-2 and Osterix transcripts were similarly expressed by adult and pediatric iliac crest
BMSCs in response to rhBMP-2. These data demonstrate that age and skeletal site-specific
differences exist in BMSC osteogenic responsiveness to BMP-2 stimulation and suggest that MSX-2
and Osterix may be potential regulatory transcription factors in BMP-mediated osteogenesis of adult
orofacial cells.
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Introduction
Skeletal homeostasis is maintained by bone marrow stromal cells (BMSCs), a major source of
osteoprogenitor cells for bone renewal based on their multipotent properties and capacity to
respond to stimulation by hormones and growth factors [1–3]. Bone morphogenetic proteins
(BMPs) are potent osteogenic stimulants; they belong to the transforming growth factor-β
(TGF-β) super family that promote osteoblast differentiation in vitro and play key roles in bone
formation in vivo [4–6].
In adults, BMP-2 and BMP-7 have broadest orthopedic and dental applications because in
vitro studies have shown they stimulate the entire process of stem cell differentiation into
mature osteoblasts. Specifically, BMP-2 increases in vitro alkaline phosphatase activity and
gene expression of osteopontin and osteocalcin in human, rat and mouse BMSCs [6–8]. In
vivo studies have also shown that a combination of BMP-2 and retinoic acid significantly
increased healing of mouse calvarial defects within a short time [9] and ex vivo-expanded
human BMSCs isolated during pelvic or femoral osteotomy exhibited higher in vivo bone
forming capacity after exposure to BMP-2 [10–12].
BMPs appear to predominantly control growth and differentiation of cartilage and bone during
embryonic development [4,13], and age-related differences in response of canine BMSCs to
BMP-2 have been described [14]. Using cells isolated from human iliac crest and rodent femurs,
we have previously shown that human BMSCs exhibit lower in vitro osteogenic response to
BMP-2 compared to rodents [15]. Additionally, we have identified skeletal site-specific
differences in osteogenic properties of human orofacial and axial BMSCs [16]. However, it is
still unclear whether disparate BMSC responses to BMP are specie, age or skeletal site
dependent. Also, the underlying mechanisms of disparate response of human BMSCs to BMP-2
stimulation have not been clearly defined.
The present study tested the hypothesis that BMP-2 stimulation of human BMSCs is dependent
on age and skeletal site of harvest. Using human BMSCs isolated from pediatric iliac crest and
adult maxilla, mandible and iliac crest, we provide evidence that age and skeletal site-specific
differences exist in BMP-2-induced osteogenesis of BMSCs.
Materials and Methods
Bone Marrow Stromal Cell Isolation and Culture Conditions
Trabecular bone samples were collected from four healthy adult volunteers at the Hospital of
the University of Pennsylvania, and marrow aspirates from four pediatric patients at Children’s
Hospital of Philadelphia, Philadelphia PA. Written informed consent was obtained under two
Institutional Review Board-approved protocols. Mononucleated cells were harvested from
maxilla and mandible (orofacial) trabecular bone samples and iliac crest (axial) marrow of
adult donors; and also from iliac crest marrow aspirates of pediatric donors. Primary cultures
of BMSCs were established from all samples in α-modified minimum essential medium (α-
MEM) supplemented with 20% fetal bovine serum (FBS) (Equitech Bio, Kerville, TX), 100
U/ml penicillin, 100 mg/ml streptomycin sulfate and 2 mM glutamine (all reagents from Gibco,
Invitrogen, Carlsbad, CA unless otherwise stated) incubated at 37°C in a humidified
atmosphere of 5% CO2 and air as previously described [16]. Sub-confluent primary BMSCs
were either stored in liquid nitrogen or further expanded in culture so that lower passage
BMSCs (passages 2 to 4) were used for all experiments.
Treatment of Bone Marrow Stromal Cells With Recombinant Human BMP-2 (rhBMP-2)
In separate 6-well plates, early passage maxilla and mandible (orofacial) and iliac crest (axial)
BMSCs were seeded at 1 × 104 cells/cm2 in growth medium as described above. Twenty four
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hours after seeding, growth medium was changed to osteogenic medium consisting of α-MEM
supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin sulfate, 2 mM
glutamine and 0.35 mM L-ascorbic acid 2-phosphate (Wako Pure Chemical Industries, Ltd.,
Japan). On day 4, BMSCs were exposed to six different culture conditions as follows: 1)
osteogenic medium supplemented with or 2) without 100 ng/ml of rhBMP-2 (R&D Systems,
Minneapolis, MN); 3) serum-free insulin containing osteogenic medium in which FBS was
replaced with 0.1 % ITS Universal Culture Supplement Premix (BD Biosciences, San Jose,
CA) with or 4) without 100 ng/ml rhBMP-2; and 5) serum-free osteogenic medium in which
FBS was replaced with 1.25 % bovine serum albumin (Sigma-Aldrich, St. Louis, MO) with or
6) without 100 ng/ml rhBMP-2. The cells were maintained in their respective culture conditions
with daily medium changes until analyzed on day 7 (i.e. 3 days after exposure to rhBMP-2).
Analysis of Effect of Culture Conditions on rhBMP-2 –induced Proliferation of Bone Marrow
Stromal Cells
After 3-day BMP-2 treatment under the six culture parameters listed above, actively
proliferating cells were assessed using WST-1 cell viability assay (Roche Applied Science,
Indianapolis IN) following manufacturer’s protocol as previously described [17]. Number of
actively proliferating cells was directly proportional to absorbance at 450 nm measured with
Multiskan MCC microplate reader (Thermo Fisher Scientific, Waltham, MA). Based on this
preliminary WST-1 cell survival results that showed no BMP-2 –associated differences among
the culture conditions, only serum-containing and insulin-containing culture parameters (i.e.
#1 to 4 above) were further evaluated in this study.
Analysis of Live Bone Marrow Stromal Cells and Alkaline Phosphatase Activity
In separate experiments for assessment of alkaline phosphatase activity, numbers of viable
cells were estimated using CellTiter 96 Aqueous One Solution Cell Proliferation Assay (MTS,
Promega Corp., Madison, WI) before harvesting the cells for alkaline phosphatase analysis.
Briefly, BMSCs were washed once with Hank’s Buffered Salt Solution (HBSS), before adding
200 μl MTS reagent (1:10 volume/volume in phenol red-free α-MEM). Cells were incubated
for 15 min at 37°C in a humidified, 5% CO2 atmosphere. MTS-containing medium from each
well was transferred to 96-well plates to measure absorbance at 490 nm. Subsequently, BMSCs
were washed twice with HBSS, lysed in 10% Triton X-100 and kept at 4°C. Alkaline
phosphatase activity was determined kinetically by monitoring conversion of p-nitrophenyl
phosphate to p-nitrophenol over 10-minutes as previously described [7]. Alkaline phosphatase
activity was calculated as nM p-nitrophenol released per minute, further normalized to live cell
number to obtain specific alkaline phosphatase activity/cell.
Real-Time PCR Analysis of rhBMP-2-Treated Bone Marrow Stromal Cells
BMSCs from the different culture conditions were harvested using Trizol reagent (Invitrogen,
Carlsbad, CA) and total RNA was isolated following manufacturer’s protocol. 2 μg of total
mRNA was converted into cDNA using oligo (dT) and the SuperScript First-Strand Synthesis
System for RT-PCR (Invitrogen, Carlsbad, CA). Real-time PCR reaction was carried out in
ABI 7300 Real-Time PCR System using Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA) and gene-specific primers were designed with the Primer Express
software (Applied Biosystems, Foster City, CA). The following primer sequences were used:
human alkaline phosphatase, forward, 5′-CCGTGGCAACTCTATCTTTGG-3′, reverse, 5′-
GATGGCAGTGAAGGGCTTCTT-3′; human osteopontin, forward, 5′-
TGGAAAGCGAGGAGTTGAATG-3′, reverse, 5′-
CATCCAGCTGACTCGTTTCATAA-3′; human RUNX2/CBFA1, forward, 5′-
TCAGCACCACAAGCCACTTC-3′, reverse, 5′-GGTCGGAGAATGGGTTCAGTT-3′;
human Osterix, forward, 5′-ACTCACACCCGGGAGAAGAA-3′, reverse, 5′-
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GGTGGTCGCTTCGGGTAAA-3′ and human MSX-2, forward, 5′-
GCACCCTGAGGAAACACAAG-3′, reverse, 5′-CGAGGAGCTGGGATGTGGTA-3′.
TATA binding protein (TBP), forward, 5′-GGAGCTGTGATGTGAAGTTTCCTA-3′,
reverse, 5′-CCAGGAAATAACTCTGGCTCATAAC-3′ was used as normalizing control.
Results were expressed as relative fold change using the ΔΔCt method (Applied Biosystems,
Foster City CA).
Statistical Analysis
Results from triplicate experiments from each subject were expressed as mean ± standard
deviation. BMP-2 effects on BMSCs were presented as fold change or percent change relative
to control untreated BMSCs. Data analysis was by two-way analysis of variance (ANOVA)
followed by post-hoc comparisons with Holm-Sidak test using SigmaStat 3.1 statistical
package (Systat Software, Inc., Chicago, IL). Statistical significance was set at P < 0.05.
Results
Skeletal site and age-related differences in rhBMP-2-induced alkaline phosphatase
expression
BMSCs isolated from four pediatric (ages 6 to 9 years) and four adult (ages 17 to 25 years)
patients (Table 1) were tested for age and skeletal site-dependent response to BMP-2
stimulation under different culture conditions. There were no significant differences in
proliferation of adult (Figure 1) or pediatric (data not shown) BMSCs among the different
culture conditions when rhBMP-2 was added to the culture media. This confirmed that 100 ng/
ml rhBMP-2 was conducive to cell survival irrespective of culture condition and the BMSCs
continued proliferating to confluent monolayer by day 7 with or without BMP-2 stimulation
(data not shown). Adult BMSCs from maxilla and mandible were more responsive to BMP-2
stimulation based on higher alkaline phosphatase mRNA in 2 of 4 patients while iliac crest
BMSCs from all 4 adult patients were unresponsive (Figure 2A). In contrast, 3 of 4 pediatric
iliac crest BMSCs responded to BMP-2 stimulation like adult maxilla and mandible BMSCs
by displaying comparatively similar increase in alkaline phosphatase mRNA (Figure 2B) and
activity (data not shown). Further testing of additional pediatric BMSCs (n =12) in our cell
library confirmed a statistically significant increase in alkaline phosphatase activity by
pediatric BMSCs in response to BMP-2 (p < 0.01) (Figure 2C). These alkaline phosphatase
results indicate skeletal site and age-related differences in BMSCs responsiveness to BMP-2
stimulation. Adult maxilla, mandible and pediatric iliac crest BMSCs demonstrated similar
BMP-2 responsiveness while adult iliac crest BMSCs were less responsive.
Insulin-Containing Culture Affects Alkaline Phosphatase Levels in rhBMP-2–Treated Bone
Marrow Stromal Cells
We have previously reported that switching culture conditions to serum-free insulin-containing
medium enhanced BMP-induced early osteogenic response of adult human femoral BMSCs
(4). Similarly, insulin-mediated increase in alkaline phosphatase activity in response to BMP-2
was recapitulated in pediatric iliac crest BMSCs (Figure 3A). To further define this response,
we evaluated effect of age and skeletal sites on insulin-mediated BMP-2 responsiveness of
adult BMSCs by real time PCR. Higher levels of alkaline phosphatase mRNA transcripts were
displayed by 3 of 4 adult orofacial BMSCs compared to iliac crest cells (Figure 3B). Despite
individual variability, insulin effect on adult BMSCs response to BMP-2 appeared to be skeletal
site-dependent. Adult iliac crest BMSCs from 3 of 4 donors (Figure 3B) did not respond as
pediatric iliac crest cells, which further suggests that insulin effect on BMP-2 response may
be age-dependent.
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Skeletal Site and Age-Related Differences in BMP-Induced Osteopontin Expression
In serum-containing medium, osteopontin gene was generally poorly expressed by adult iliac
crest and 3 of 4 maxilla and mandible BMSCs in response to BMP-2 stimulation (Figure 4A).
However, pediatric iliac crest unlike adult iliac crest BMSCs were slightly more BMP-2-
responsive (Figure 4B); which further supports possible age-related effects. Additionally,
switching to insulin-containing medium enhanced osteopontin gene expression in adult maxilla
and mandible BMSCs (Figure 4C) similar to the alkaline phosphatase response presented in
Figure 3B. This further confirms that insulin effect on BMSC BMP-2 responsiveness is
apparently skeletal site-dependent.
Effect of rhBMP-2 on Activation of Osterix and MSX-2
Assessment of BMP-2-mediated osteogenesis based on gene expression of RUNX2, the master
osteogenic transcription factor, did not show any difference between control and BMP-2
stimulated BMSCs in either adult or pediatric BMSCs (data not shown) as previously described
in earlier reports [3]. We further assessed gene expression levels of Osterix and MSX-2 that
can be activated independent of RUNX2. In serum-free insulin-containing medium, BMP-2
enhanced MSX-2 (Figure 5A) and Osterix (Figure 5B) gene expression in adult maxilla,
mandible and iliac crest BMSCs with mandible showing the highest response and Osterix
mRNA much more elevated than MSX-2. In contrast, Osterix and MSX-2 mRNA levels were
much lower in adult maxilla and mandible BMSCs under serum-containing culture conditions
(data not shown) and there were no significant differences between expression levels of Osterix
and MSX-2 in either adult or pediatric iliac crest BMSCs (Figure 5C and D).
Discussion
We evaluated the effects of age and skeletal site-specificity on BMP-2-mediated osteogenic
differentiation of human BMSCs from adult maxilla, mandible and iliac crest and pediatric
iliac crest. Previously, we have established the existence of site-specific variations in the
response of orofacial (maxilla and mandible) and iliac crest human BMSCs to osteogenic and
adipogenic inducers in vitro as well as their in vivo bone regenerative capacity [16]. Adult
orofacial BMSCs were reported to be more responsive to osteogenic inducers in vitro and
regenerated quantitatively more bone in vivo. Those initial studies were confined to the use of
osteogenic medium that contained ascorbic acid and dexamethasone while BMPs and other
osteogenic growth factors were not tested. The current study advanced the previous work by
further testing age and skeletal site-specific osteogenic response of BMSCs to BMP-2
stimulation.
The osteogenic effects and therapeutic potential of rhBMP-2 is well recognized using animal
and human BMSC cultures [18]. But human BMSCs are apparently less responsive to BMP
stimulation than animal cells. Our previous studies demonstrated that adult human femoral
BMSCs treated with rhBMP-2 did not exhibit higher expression of either alkaline phosphatase
or osteopontin under standard culture conditions but needed modifications of culture conditions
before undergoing osteogenic differentiation [3]. Consistent with this report, our present study
indicated that adult human iliac crest BMSCs responded like femoral cells and did not display
appreciable osteogenic response to rhBMP-2. Although insulin/Insulin Growth Factor
signaling pathway acts synergistically with BMP pathway in adult human mesenchymal stem
cells to induce gene expression [19], adult iliac crest BMSCs were still osteogenically less
responsive to rhBMP-2 stimulation when cultured in serum-free insulin-containing medium.
This is consistent with similar reports on vertebral body-derived adult human BMSCs that also
displayed limited osteogenic response to rhBMP-2 in a defined serum-free culture condition
[20].
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The minimal response of adult iliac crest BMSCs prompted further evaluation of age-related
effects on BMP-2 response. The impact of age is relevant in rodents considering that BMSCs
usually isolated from young animals are readily responsive to BMP stimulation. In humans,
these age-related effects still need to be further clarified [21–23]. The human pediatric iliac
crest BMSCs evaluated in this study were more osteogenically responsive to BMP-2
stimulation than adult cells based on elevated alkaline phosphatase and osteopontin mRNA
levels. These observations support the existence of age-related BMP-2 responsiveness of iliac
crest BMSCs and are consistent with earlier reports that rhBMP-2 treated BMSCs from young
subjects have high bone forming capacity [12,14,24]. However, further studies on long-term
osteogenesis, effects on bone remodeling and osteoblast-osteoclast balance are still needed to
fully understand the underlying mechanisms.
In contrast to the low response of adult iliac crest BMSCs, orofacial (maxilla and mandible)
BMSCs displayed high expression of alkaline phosphatase and osteopontin in response to
rhBMP-2. This is consistent with our previous report that orofacial BMSCs have greater
osteogenic potential in culture [16] and underscores the existence of skeletal site-specificity
of BMSC osteogenesis. Skeletal site-specificity of BMSCs may be due to their different
embryological origins because craniofacial bones arise from neural crest while axial and
appendicular bones arise from mesoderm. Similarly, craniofacial bones have dual
intramembranous and endochondral ossification patterns while axial and appendicular bones
undergo only endochondral ossification. During endochondral ossification, BMPs are thought
to serve more as inducers of mesenchymal condensation and chondrogenic differentiation
rather than bone inducers [25,26]. On the other hand, recent studies have shown that BMPs
influence differentiation of neural crest-derived mesenchyme into bone [27] and exogenous
treatment of avian mandible with BMP resulted in accelerated osteogenesis [28]. It is
noteworthy that BMP-2 did not alter proliferative capacity of BMSCs tested in this study
(Figure 1), further highlighting that these disparate BMP-2 mediated responses were more
related to BMSC differentiation and not cell number.
We assessed the possibility that disparate BMP-induced expressions of early osteogenic genes
like alkaline phosphatase and osteopontin indicate age and skeletal site-specific variations in
expression of three osteogenic transcription factors, namely RUNX2, MSX-2 and Osterix.
BMSCs were kept in culture for 7 days in this study, so it was not surprising that mRNA levels
of RUNX2, an early marker of osteoblast differentiation, remained unchanged in both pediatric
and adult BMP-treated cells (data not shown) because RUNX2 expression is usually transiently
elevated within the first hours of BMP treatment in adult BMSCs [25,29]. Since actions of
Osterix and MSX-2 are interrelated [30–32] and BMP-2 directly regulates MSX-2 gene
expression through Smad binding elements in a promoter region [33], it is possible that BMPs
can indirectly activate Osterix expression through MSX-2 [32] or DLX-5 [34] without
involving RUNX2, the master osteogenic transcription factor [25]. Therefore, we focused on
Osterix and MSX-2 expression levels in assessing skeletal site and age-related effects on
BMSCs response to BMP-2. In contrast to unchanged expression of RUNX2, induction of
MSX-2 and Osterix mRNAs was sustained in response to BMP-2 stimulation. The higher levels
of Osterix and MSX-2 mRNA displayed by maxilla and mandible relative to iliac crest BMSC
were consistent with similarly high expressions of alkaline phosphatase and osteopontin.
Therefore, adult maxilla and mandible may have responded by activation of MSX-2 and Osterix
while iliac crest cells probably responded to BMP-2 by a different mechanism. Understanding
these mechanisms will further illuminate age-related differences between pediatric and adult
iliac crest BMSCs that displayed similar levels of MSX-2 and Osterix despite pediatric cells
being more responsive to BMP-2. The small number of BMSC samples tested is one limitation
of this study. But testing BMSCs from four adult and four pediatric subjects was in accordance
with earlier studies that showed sample size of 4 was adequate to demonstrate statistically
significant cellular response in mesenchymal stem cells obtained from different skeletal sites
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in same individuals [16,17]. To minimize individual variability, maxilla, mandible and iliac
crest BMSCs from each adult subject were matched so that cells from same individuals were
evaluated together. Another limitation was that only pediatric iliac crest BMSCs were tested,
but this decision was based on ethical guidelines of the experimental design.
In summary, this study showed that age and skeletal site-specific differences exist in BMP-2-
induced BMSC osteogenesis. BMP-mediated osteogenesis of pediatric iliac crest and adult
orofacial BMSCs were generally higher than adult iliac crest cells. Our results suggest that
Osterix and MSX-2 are potential regulatory transcription factors in BMP-mediated
osteogenesis of adult orofacial cells. Further elucidation of underlying mechanisms of this
disparate BMP-2 response is still needed.
Acknowledgments
The authors thank Dr. D. LaRossa, Division of Plastic and Reconstructive Surgery, Department of Pediatric Plastic
Surgery, Children’s Hospital of Philadelphia for pediatric bone marrow samples and appreciate the support of Dr.
Phoebe Leboy, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA. Funding for this study was
provided in part by DHHS/NIH grants 5-R03-AG-026047-02 and 1K08CA120875-01 awarded to S.O.A and MIRG-
CT-2007-046479 grant within EC 6FP and 465/6.PRUE/2007/7 subsidiary financing from Polish Ministry of Science
and Education awarded to A.M.O.
References
1. Andrades JA, Santamaria JA, Nimni ME, Becerra J. Selection and amplification of a bone marrow cell
population and its induction to the chondro-osteogenic lineage by rhOP-1: an in vitro and in vivo study.
Int J Dev Biol 2001;45:689–693. [PubMed: 11461007]
2. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic
stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology
1994;134:277–286. [PubMed: 8275945]
3. Osyczka AM, Leboy PS. Bone morphogenetic protein regulation of early osteoblast genes in human
marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-
kinase signaling. Endocrinology 2005;146:3428–3437. [PubMed: 15905316]
4. Bonn D. The application of cell biology to broken bones. Lancet 1999;353:650. [PubMed: 10030341]
5. Wang EA, Rosen V, D’Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, et al. Recombinant
human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990;87:2220–
2224. [PubMed: 2315314]
6. Fromigue O, Marie PJ, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta2
interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem
1998;68:411–426. [PubMed: 9493905]
7. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. Induction of rapid osteoblast
differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol
1994;161:218–228. [PubMed: 8293874]
8. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V. Recombinant human bone
morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology
1992;130:1318–1324. [PubMed: 1311236]
9. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, et al. Bone morphogenetic
protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover.
Tissue Eng 2005;11:645–658. [PubMed: 15869441]
10. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in
cultured human bone marrow stromal cells. J Bone Joint Surg Am 2003;85-A(Suppl 3):19–28.
[PubMed: 12925605]
11. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal
stem cells. Connect Tissue Res 2003;44(Suppl 1):305–311. [PubMed: 12952214]
Osyczka et al. Page 7
Connect Tissue Res. Author manuscript; available in PMC 2010 July 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
12. Yamagiwa H, Endo N, Tokunaga K, Hayami T, Hatano H, Takahashi HE. In vivo bone-forming
capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone
morphogenetic protein-2. J Bone Miner Metab 2001;19:20–28. [PubMed: 11156469]
13. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, et al. Effect of
recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.
Journal of Bone & Mineral Research 1998;13:1483–1490. [PubMed: 9738522]
14. Volk SW, Diefenderfer DL, Christopher SA, Haskins ME, Leboy PS. Effects of osteogenic inducers
on cultures of canine mesenchymal stem cells. Am J Vet Res 2005;66:1729–1737. [PubMed:
16273904]
15. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow
stromal cells from human and rat bone. Cells Tissues Organs 2004;176:109–119. [PubMed:
14745240]
16. Akintoye SO, Lam T, Shi S, Brahim J, Collins MT, Robey PG. Skeletal site-specific characterization
of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 2006;38:758–
768. [PubMed: 16403496]
17. Stefanik D, Sarin J, Lam T, Levin L, Leboy PS, Akintoye SO. Disparate osteogenic response of
mandible and iliac crest bone marrow stromal cells to pamidronate. Oral Dis 2008;14:465–471.
[PubMed: 18938273]
18. Kirker-Head CA, Boudrieau RJ, Kraus KH. Use of bone morphogenetic proteins for augmentation
of bone regeneration. J Am Vet Med Assoc 2007;231:1039–1055. [PubMed: 17916029]
19. Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression
in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol
Chem 2005;280:31353–31359. [PubMed: 16000303]
20. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem
cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006;98:538–554. [PubMed:
16317727]
21. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived
mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008;129:163–173.
[PubMed: 18241911]
22. Tokalov SV, Gruener S, Schindler S, Iagunov AS, Baumann M, Abolmaali ND. A number of bone
marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with
age of rats. Mol Cells 2007;24:255–260. [PubMed: 17978579]
23. Zhang W, Ou G, Hamrick M, Hill W, Borke J, Wenger K, Chutkan N, et al. Age-related changes in
the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res
2008;23:1118–1128. [PubMed: 18435580]
24. Matsumoto A, Yamaji K, Kawanami M, Kato H. Effect of aging on bone formation induced by
recombinant human bone morphogenetic protein-2 combined with fibrous collagen membranes at
subperiosteal sites. J Periodontal Res 2001;36:175–182. [PubMed: 11453116]
25. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development.
Dev Cell 2002;2:389–406. [PubMed: 11970890]
26. Tsumaki N, Yoshikawa H. The role of bone morphogenetic proteins in endochondral bone formation.
Cytokine Growth Factor Rev 2005;16:279–285. [PubMed: 15869898]
27. Abzhanov A, Rodda SJ, McMahon AP, Tabin CJ. Regulation of skeletogenic differentiation in cranial
dermal bone. Development 2007;134:3133–3144. [PubMed: 17670790]
28. Merrill AE, Eames BF, Weston SJ, Heath T, Schneider RA. Mesenchyme-dependent BMP signaling
directs the timing of mandibular osteogenesis. Development 2008;135:1223–1234. [PubMed:
18287200]
29. Kim IS, Song YM, Cho TH, Park YD, Lee KB, Noh I, Weber F, et al. In vitro response of primary
human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early
and late stages of osteoblast differentiation. Dev Growth Differ. 2008
30. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. MSX2 promotes osteogenesis
and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem
2003;278:45969–45977. [PubMed: 12925529]
Osyczka et al. Page 8
Connect Tissue Res. Author manuscript; available in PMC 2010 July 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
31. Kurata H, Guillot PV, Chan J, Fisk NM. Osterix induces osteogenic gene expression but not
differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 2007;13:1513–1523.
[PubMed: 17518720]
32. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, et al. BMP2 Regulates
Osterix through Msx2 and Runx2 during Osteoblast Differentiation. J Biol Chem 2008;283:29119–
29125. [PubMed: 18703512]
33. Brugger SM, Merrill AE, Torres-Vazquez J, Wu N, Ting MC, Cho JY, Dobias SL, et al. A
phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-
dependent transcription in murine and Drosophila embryos. Development 2004;131:5153–5165.
[PubMed: 15459107]
34. Ulsamer A, Ortuno MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL, Ventura F. BMP-2 induces Osterix
expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem
2008;283:3816–3826. [PubMed: 18056716]
Osyczka et al. Page 9
Connect Tissue Res. Author manuscript; available in PMC 2010 July 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. BMP-2 effects on adult BMSC proliferation unaffected by variable culture conditions
BMSCs from different skeletal sites were seeded at 1 × 104 cells/cm2 were stimulated with
and without rhBMP-2 in medium containing serum, or serum- free α-MEM with or without
insulin followed by WST-1 cell viability assay at day 7. BMSC proliferation was unaffected
by BMP-2 relative to controls (expressed as 1) and similar survival pattern was displayed
irrespective of culture conditions. [Error bars are standard deviation of mean of triplicate
experiments from each subject (n = 4)].
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Figure 2. BMP-2 stimulated alkaline phosphatase expression in adult orofacial and pediatric iliac
crest BMSCs in serum-containing medium
BMSCs seeded at 1 × 104 cells/cm2 were stimulated with and without rhBMP-2 in serum-
containing medium for 7 days followed by analysis of alkaline phosphate mRNA by real-time
PCR in (A) adult BMSCs from different skeletal sites and (B) pediatric iliac crest BMSCs.
There was high BMP-2 responsiveness of adult maxilla and mandible cells in 2 of 4 subjects
similar to pediatric iliac crest cells, while adult iliac crest cells were unresponsive. (C) Similarly
treated iliac crest BMSCs from additional pediatric subjects (n = 12; demographic information
not provided in table 1) were analyzed for BMP-2 induced change in alkaline phosphatase
activity per cell. There was a statistically significant increase in BMP-responsiveness of
pediatric iliac crest BMSCs further confirming age-related differences in iliac crest BMSCs.
[Error bars are standard deviation of mean of triplicate experiments; * = P < 0.05].
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Figure 3. Serum-free insulin-containing culture condition enhanced BMP-2-induced expression
and activity of alkaline phosphatase in pediatric iliac crest and adult orofacial BMSCs
BMSCs seeded at 1 × 104 cells/cm2 were stimulated with and without rhBMP-2 in serum-free
insulin-containing medium for 7 days followed by analysis of (A) alkaline phosphate activity
in pediatric iliac crest BMSCs (n = 4) and (B) alkaline phosphatase mRNA by real-time PCR
in adult BMSCs from different skeletal sites. Insulin increased alkaline phosphatase activity
in pediatric iliac crest cells and high mRNA increase in adult maxilla and mandible cells while
3 of 4 adult iliac crest cells were unresponsive. [Error bars are standard deviation of mean of
triplicate experiments; * = P < 0.05; ** = P < 0.01; *** = P < 0.0001].
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Figure 4. BMP-2-induced osteopontin expression in orofacial adult BMSCs is affected by culture
conditions
BMSCs seeded at 1 × 104 cells/cm2 were stimulated with and without rhBMP-2 in serum-
containing medium for 7 days followed by analysis of osteopontin mRNA from (A) adult
BMSCs from different skeletal sites and (B) pediatric iliac crest BMSCs. Osteopontin mRNA
was generally poorly expressed by BMP-treated adult BMSCs (except subject 4) unlike
pediatric iliac crest BMSCs that were generally more responsive. (C) Switching to insulin-
containing medium however supported higher osteopontin expression in maxilla and mandible
BMSCs while adult iliac crest cells were still less responsive. [Error bars are standard deviation
of mean of triplicate experiments; * = P < 0.05].
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Figure 5. BMP-2 disparately increased Osterix and MSX-1 expression in orofacial BMSCs cultured
in serum-free insulin-containing medium
BMSCs seeded at 1 × 104 cells/cm2 were stimulated with and without rhBMP-2 in serum-free
insulin-containing medium for 7 days followed by analysis of (A) MSX-2 and (B) Osterix
mRNA by real-time PCR. Moderate expression of MSX-2 and high expression of Osterix
mRNAs were induced by BMP-2 in orofacial cells (especially mandible) while iliac crest cells
were less responsive (except subject 16 in B). In the presence of serum, expression of both
MSX-2 and Osterix mRNAs were low in orofacial BMSCs (not shown) but there were no age-
related differences based on similar expression levels of MSX-2 and Osterix in both (C) adult
and (D) pediatric iliac crest BMSCs. [Error bars are standard deviation of mean of triplicate
experiments; * = P < 0.05].
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Table 1
Characteristics of BMSC donors
Subject # Age (Years) Sex
6 6 Male
7 6 Male
2 8 Male
5 9 Male
22 17 Male
4 18 Female
10 20 Male
16 25 Female
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